SREBF1 and breast carcinoma: Inducing SREBP-1 gene to activate the Akt and HIF1 in breast cancer also increased the expression of FASN, which partly conduced to hypoxia-induced chemoresistance to cyclophosphamide (Furuta et al., 2008).